ENHANCED ACUTE RESPONSES IN AN EXPERIMENTAL EXPOSURE MODEL TO BIOMASS SMOKE INHALATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

REFERENCES

• Brook R D, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith S C, Jr, Tager I. Expert Panel on Population and Prevention Science of the American Heart Association: Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004; 109: 2655–2671
   PubMed Web of Science ®Google Scholar
• Samet J M, Dominici F, Curriero F C, Coursac I, Zeger S L. Fine particulate air pollution and mortality in 20 U.S. cities, 1987–1994. N Engl J Med 2000; 343: 1742–1749
   PubMed Web of Science ®Google Scholar
• Dominici F, Peng R D, Bell M L, Pham L, McDermott A, Zeger S L, Samet J M. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 2006; 295: 1127–1134
   PubMed Web of Science ®Google Scholar
• Wellenius G A, Schwartz J, Mittleman M A. Particulate air pollution and hospital admissions for congestive heart failure in seven United States cities. Am J Cardiol 2006; 97: 404–408
   PubMed Web of Science ®Google Scholar
• Pope C A, Muhlestein J B, May H T, Renlund D G, Anderson J L, Horne B D. Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation 2006; 114: 2443–2448
   PubMed Web of Science ®Google Scholar
• Pope C A, Burnett R T, Thun M J, Calle E E, Krewski D, Ito K, Thurston G D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002; 287: 1132–1141
   PubMed Web of Science ®Google Scholar
• van Eeden S F, Tan W C, Suwa T, Mukae H, Terashima T, Fujii T, Qui D, Vincent R, Hogg J C. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med 2001; 164: 826–830
   PubMed Web of Science ®Google Scholar
• Suwa T, Hogg J C, Quinlan K B, Ohgami A, Vincent R, van Eeden S F. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002; 39: 935–942
   PubMed Web of Science ®Google Scholar
• Tan W C, Qiu D, Liam B L, Ng T P, Lee S H, van Eeden S F, D'Yachkova Y, Hogg J C. The human bone marrow response to acute air pollution caused by forest fires. Am J Respir Crit Care Med 2000; 161: 1213–1217, (4 Pt 1)
   PubMed Web of Science ®Google Scholar
• Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich J, Marder V, Frampton M, Wichmann H E, Peters A. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 2006; 173: 432–441
   PubMed Web of Science ®Google Scholar
• Tamagawa E, van Eeden S F. Impaired lung function and risk for stroke: role of the systemic inflammation response?. Chest 2006; 130: 1631–1633
   PubMed Web of Science ®Google Scholar
• Kim W D, Kim W S, Koh Y, Lee S D, Lim C M, Kim D S, Cho Y J. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest 2002; 122: 437–444
   PubMed Web of Science ®Google Scholar
• Barnes P J, Shapiro S D, Pauwels R A. COPD: molecular and cellular mechanisms. Eur Respir. J 2003; 22: 672–688
   PubMed Web of Science ®Google Scholar
• Frankenberger M, Menzel M, Betz R, Kabner G, Weber N, Kohlhaufl M, Haubinger K, Ziegler-Heitbrock L. Characterization of a population of small macrophages in induced sputum of patients with COPD and healthy volunteers. Clin Exp Immunol 2004; 138: 507–516
   PubMed Web of Science ®Google Scholar
• O'Shaughnessy T C, Ansari T W, Barnes N C, Jeffery P K. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155: 852–857
   PubMed Web of Science ®Google Scholar
• Saetta M, Baraldo S, Corbino L. CD8+ve cells in the lungs of smokers with COPD. Am J Respir Crit Care Med 1999; 160: 711–717
   PubMed Web of Science ®Google Scholar
• Hageman G J, Larik I, Pennings H J, Haenen G R, Wouters E F, Bast A. Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 2003; 35: 140–148
   PubMed Web of Science ®Google Scholar
• Schols A M, Buurman W A, Staal van den Brekel A J, Dentener M A, Wouters E F. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with COPD. Thorax 1996; 51: 819–824
   PubMed Web of Science ®Google Scholar
• Mayer C, Gruber H J, Landl E M, Pailer S, Scharnagl H, Truschnig-Wilders M, Marz W. Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion. Int J Clin Pharmacol Ther 2007; 45: 319–327
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152: 1107–1136
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117
   PubMed Web of Science ®Google Scholar
• Prieto A, Reyes E, Bernstein E D, Martinez B, Monserrat J, Izquierdo J L, Callol L, de Lucas P, Alvarez-Sala R, Alvarez-Sala J L, Villarrubia V G. Alvarez-Mon M. Defective natural killer and phagocytic activities in COPD are restored by glycophosphopeptical (Inmunoferon). Am J Respir Crit Care Med 2001; 163: 1578–1583
   PubMed Web of Science ®Google Scholar
• Lewis S A, Pavord I D, Stringer J R, Knox A J, Weiss S T, Britton J R. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest 2001; 119: 105–114
   PubMed Web of Science ®Google Scholar
• Cosio M G, Majo J, Cosio M G. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002; 121: 160S–165S
   PubMed Web of Science ®Google Scholar
• Pons A R, Noguera A, Blanquer D, Sauleda J, Pons J, Agusti A GN. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J 2005; 25: 647–652
   PubMed Web of Science ®Google Scholar
• Oudijk E J, Nijhuis E H, Zwank M D, van de Graaf E A, Mager H J, Coffer P J, Lammers J W, Koenderman L. Systemic inflammation in COPD visualized by gene profiling in peripheral blood neutrophils. Thorax 2005; 60: 538–544
   PubMed Web of Science ®Google Scholar
• Tzouvelekis A, Patlakas G, Bouros D. Application of microarray technology in pulmonary diseases. Respir Res 2004; 5: 26–43
   PubMed Web of Science ®Google Scholar
• Higashimoto Y, Yamagata Y, Iwata T, Okada M, Ishiguchi T, Sato H, Masuda M, Itoh H. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients. Eur Respir. J 2005; 25: 885–890
   Google Scholar
• Lambert E, Dasse E, Haye B, Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004; 49: 187–198
   PubMed Web of Science ®Google Scholar
• Azimi N, Shiramizu K M, Tagaya Y, Mariner J, Waldmann T A. Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region. J Virol 2000; 74: 7338–7348
   PubMed Web of Science ®Google Scholar
• Libermann T A, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990; 10: 2327–2334
   PubMed Web of Science ®Google Scholar
• Kuprash D V, Osipovich O A, Pokholok D K, Alimzhanov M B, Biragyn A, Turetskaya R L, Nedospasov S A. Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation. J Immunol 1996; 156: 2465–2472
   PubMed Web of Science ®Google Scholar
• Yi-qun Z, Joost van Neerven R J, Kasran A, de Boer M, Ceuppens J L. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int Immunol 1996; 8: 37–44
   PubMed Web of Science ®Google Scholar
• Kim C H, Kunkel E J, Boisvert J, Johnston B, Campbell J J, Genovese M C, Greenberg H B, Butcher E C. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extra lymphoid tissue homing potential. J Clin Invest 2001; 107: 595–601
   PubMed Web of Science ®Google Scholar
• Carramolino L, Zaballos A, Kremer L, Villares R, Martin P, Ardavin C, Martinez A C, Marquez G. Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs. Blood 2001; 97: 850–857
   PubMed Web of Science ®Google Scholar
• Bratke K, Kuepper M, Bade B, Virchow J C, Jr, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol 2005; 35: 2608–2616
   PubMed Web of Science ®Google Scholar
• Churg A, Xie C, Wang X, Vincent R, Wang R D. Air pollution particles activate NF-kappaB on contact with airway epithelial cell surfaces. Toxicol Appl Pharmacol 2005; 208: 37–45
   PubMed Web of Science ®Google Scholar
• Lai J H, Horvath G, Subleski J, Bruder J, Ghosh P, Tan T H. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol Cell Biol 1995; 15: 4260–4271
   PubMed Web of Science ®Google Scholar
• Sancho D, Yanez-Mo M, Tejedor R, Sanchez-Madrid F. Activation of peripheral blood T cells by interaction and migration through endothelium: role of lymphocyte function antigen-1/intercellular adhesion molecule-1 and interleukin-15. Blood 1999; 93: 886–896
   PubMed Web of Science ®Google Scholar
• Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005; 52: 3004–3014
   PubMed Web of Science ®Google Scholar
• Agostini C, Zambello R, Facco M, Perin A, Piazza F, Siviero M, Basso U, Bortolin M, Trentin L, Semenzato G. CD8 T-cell infiltration in extra vascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood 1999; 93: 1277–1286
   PubMed Web of Science ®Google Scholar
• Mattei F, Schiavoni G, Belardelli F, Tough D F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 2001; 167: 1179–1187
   PubMed Web of Science ®Google Scholar
• Zabel B A, Agace W W, Campbell J J, Heath H M, Parent D, Roberts A I, Ebert E C, Kassam N, Qin S, Zovko M, LaRosa G J, Yang L L, Soler D, Butcher E C, Ponath P D, Parker C M, Andrew D P. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 1999; 190: 1241–1256
   PubMed Web of Science ®Google Scholar
• van der Voort R, van Lieshout A W, Toonen L W, Sloetjes A W, van den Berg W B, Figdor C G, Radstake T R, Adema G J. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum 2005; 52: 1381–1391
   PubMed Web of Science ®Google Scholar
• Agostini C, Cabrelle A, Calabrese F, Bortoli M, Scquizzato E, Carraro S, Miorin M, Beghe B, Trentin L, Zambello R, Facco M, Semenzato G. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med 2005; 172: 1290–1298
   PubMed Web of Science ®Google Scholar
• Morgan A J, Guillen C, Symon F A, Huynh T T, Berry M A, Entwisle J J, Briskin M, Pavord I D, Wardlaw A J. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy 2005; 35: 1572–1580
   PubMed Web of Science ®Google Scholar
• Ku C C, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000; 288: 675–678
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Haanen J, Spits H, Roncarolo M G, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries J E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–924
   PubMed Web of Science ®Google Scholar
• Buelens C, Willems F, Delvaux A, Pierard G, Delville J P, Velu T, Goldman M. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 1995; 25: 2668–2672
   PubMed Web of Science ®Google Scholar
• Nakagome K, Dohi M, Okunishi K, Komagata Y, Nagatani K, Tanaka R, Miyazaki J, Yamamoto K. In vivo IL-10 gene delivery suppresses airway eosinophilia and hyper-reactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J Immunol 2005; 174: 6955–6966
   PubMed Web of Science ®Google Scholar
• Aw D, Silva A B, Palmer D B. Immunosenescence: emerging challenges for an ageing population. Immunology 2007; 120: 435–446
   PubMed Web of Science ®Google Scholar
• Weng N P. Aging of the immune system: how much can the adaptive immune system adapt?. Immunity 2006; 24: 495–499
   PubMed Web of Science ®Google Scholar
• Tayebjee M H, Lip G Y, Tan K T, Patel J V, Hughes E A, MacFadyen R J. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 2005; 96: 339–345
   PubMed Web of Science ®Google Scholar
• Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001; 141: 211–217
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun M, Samols D, Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 1996; 271: 9503–9509
   PubMed Web of Science ®Google Scholar
• Harris T B, Ferrucci L, Tracy R P, Corti M C, Wacholder S, Ettinger W H, Jr, Heimovitz H, Cohen H J, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: 506–512
   PubMed Web of Science ®Google Scholar
• Wettinger S B, Doggen C J, Spek C A, Rosendaal F R, Reitsma P H. High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood 2005; 105: 2000–2006
   PubMed Web of Science ®Google Scholar
• Hauer A D, Uyttenhove C, de Vos P, Stroobant V, Renauld J C, van Berkel T J, van Snick J, Kuiper J. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005; 112: 1054–1062, Erratum in Circulation. 2005;112:e293
   PubMed Web of Science ®Google Scholar
• Rangachari M, Mauermann N, Marty R R, Dirnhofer S, Kurrer M O, Komnenovic V, Penninger J M, Eriksson U. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006; 203: 2009–2019
   PubMed Web of Science ®Google Scholar
• Wilson N J, Boniface K, Chan J R, McKenzie B S, Blumenschein W M, Mattson J D, Basham B, Smith K, Chen T, Morel F, Lecron J C, Kastelein R A, Cua D J, McClanahan T K, Bowman E P, de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950–957
   PubMed Web of Science ®Google Scholar
• Sonderegger I, Rohn T A, Kurrer M O, Iezzi G, Zou Y, Kastelein R A, Bachmann M F, Kopf M. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent auto-immune myocarditis. Eur J Immunol 2006; 36: 2849–2856
   PubMed Web of Science ®Google Scholar